Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 3546 entries
View as:

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02729051 Org: User:
Start: 06/29/16 End: 05/23/17 Due: 05/23/18

Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00268177 Org: User:
Start: 10/31/02 End: 12/31/03 Due: 12/31/04

A Study of GSK5764227 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06551142 Org: User:
Start: 09/30/24 End: 03/19/27 Due: 03/19/28

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

Phase: N/A Priority: Normal
NCT ID: NCT00698490 Org: User:
Start: 08/31/95 End: 01/31/97 Due: 01/31/98

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02322671 Org: User:
Start: 02/23/15 End: 04/20/15 Due: 04/20/16

A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00439868 Org: User:
Start: 02/16/07 End: 06/08/07 Due: 06/08/08

Treatment Of Patients With Social Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00397722 Org: User:
Start: 11/09/06 End: 09/05/07 Due: 09/05/08

A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

Phase: N/A Priority: Normal
NCT ID: NCT01627587 Org: User:
Start: 12/12/11 End: 02/09/12 Due: 02/09/13

GSK2190915 Neutrophilic Asthma Study

Phase: N/A Priority: Normal
NCT ID: NCT01471665 Org: User:
Start: 06/30/11 End: 05/31/12 Due: 05/31/13

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT00319098 Org: User:
Start: 05/01/06 End: 07/31/07 Due: 07/31/08

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Phase: N/A Priority: Normal
NCT ID: NCT00695669 Org: User:
Start: 06/05/08 End: 01/08/09 Due: 01/08/10

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00635128 Org: User:
Start: 02/01/08 End: 07/08/08 Due: 07/08/09

Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03227445 Org: User:
Start: 09/20/17 End: 01/04/18 Due: 01/04/19

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

Phase: N/A Priority: Normal
NCT ID: NCT00609596 Org: User:
Start: 02/26/08 End: 04/23/08 Due: 04/23/09

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00540501 Org: User:
Start: 10/31/07 End: 10/31/07 Due: 10/31/08

This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02324218 Org: User:
Start: 10/31/14 End: 01/31/15 Due: 01/31/16

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Phase: N/A Priority: Normal
NCT ID: NCT05553808 Org: User:
Start: 01/24/19 End: 09/23/21 Due: 09/23/22

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Phase: N/A Priority: Normal
NCT ID: NCT03275389 Org: User:
Start: 09/08/17 End: 03/26/20 Due: 03/26/21

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02981602 Org: User:
Start: 02/24/17 End: 12/26/19 Due: 12/26/20

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Phase: N/A Priority: Normal
NCT ID: NCT00411697 Org: User:
Start: 12/31/06 End: 05/31/07 Due: 05/31/08

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04128696 Org: User:
Start: 11/21/19 End: 06/20/23 Due: 06/20/24

Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children

Phase: N/A Priority: Normal
NCT ID: NCT02742753 Org: User:
Start: 06/16/16 End: 09/14/17 Due: 09/14/18

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01582997 Org: User:
Start: 05/11/12 End: 04/16/15 Due: 04/16/16

Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01462669 Org: User:
Start: 04/10/12 End: 06/27/12 Due: 06/27/13

A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT01147861 Org: User:
Start: 07/01/10 End: 09/07/10 Due: 09/07/11